Loading...
Joinn Laboratories(China)Co.,Ltd.
6127.HK•HKSE
Healthcare
Medical - Diagnostics & Research
HK$16.68
HK$0.54(3.35%)
Joinn Laboratories(China)Co.,Ltd. (6127.HK) Financial Performance & Statements
Review Joinn Laboratories(China)Co.,Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-15.07%
↓ 15.07%
Operating Income Growth
-79.42%
↓ 79.42%
Net Income Growth
-81.34%
↓ 81.34%
Operating Cash Flow Growth
-45.59%
↓ 45.59%
Operating Margin
22.55%
↑ 22.55%
Gross Margin
25.45%
↑ 25.45%
Net Profit Margin
19.56%
↑ 19.56%
ROE
4.83%
↑ 4.83%
ROIC
5.36%
↑ 5.36%
Joinn Laboratories(China)Co.,Ltd. (6127.HK) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Joinn Laboratories(China)Co.,Ltd. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $683.18M | $484.29M | $524.55M | $322.44M |
| Cost of Revenue | $476.31M | $376.83M | $373.27M | $218.16M |
| Gross Profit | $206.87M | $107.46M | $151.28M | $104.28M |
| Gross Profit Ratio | $0.30 | $0.22 | $0.29 | $0.32 |
| R&D Expenses | $21.83M | $23.25M | $24.87M | $22.97M |
| SG&A Expenses | -$137.46M | $187.76M | -$2.56M | $79.68M |
| Operating Expenses | $32.86M | $1.48M | $115.67M | $128.91M |
| Total Costs & Expenses | $509.17M | $378.31M | $488.93M | $347.07M |
| Interest Income | $20.70M | $24.50M | $90.70M | $29.07M |
| Interest Expense | $620119.00 | $579389.00 | $4.03M | $653474.00 |
| Depreciation & Amortization | $0.00 | $1.79M | -$282.28M | $24.65M |
| EBITDA | $174.55M | $109.29M | $115.13M | -$255.68M |
| EBITDA Ratio | $0.26 | $0.23 | $0.22 | -$0.79 |
| Operating Income | $174.008M | $107.49M | $115.85M | -$24.63M |
| Operating Income Ratio | $0.25 | $0.22 | $0.22 | -$0.08 |
| Other Income/Expenses (Net) | -$76979.00 | -$34890.00 | -$74625.00 | -$267.94M |
| Income Before Tax | $173.93M | $107.46M | $115.78M | -$292.57M |
| Income Before Tax Ratio | $0.25 | $0.22 | $0.22 | -$0.91 |
| Income Tax Expense | $29.93M | $9.46M | $14.65M | -$19.77M |
| Net Income | $144.38M | $99.44M | $102.48M | -$272.22M |
| Net Income Ratio | $0.21 | $0.21 | $0.20 | -$0.84 |
| EPS | $0.00 | $0.13 | $0.14 | -$0.36 |
| Diluted EPS | $0.00 | $0.13 | $0.14 | -$0.36 |
| Weighted Avg Shares Outstanding | $0.00 | $749.48M | $737.03M | $749.89M |
| Weighted Avg Shares Outstanding (Diluted) | $0.00 | $749.48M | $737.03M | $749.89M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan